Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 434.50
+4.70 (1.09%)
Apr 15, 2026, 4:54 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 96.78 billion as of April 15, 2026. Its market cap has decreased by -40.73% in one year.
Market Cap
96.78B
Enterprise Value
120.75B
Revenue
27.89B
Ranking
n/a
PE Ratio
24.29
Stock Price
434.50
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 96.78B, an increase of 1,545.86%. That is a compound annual growth rate of 10.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 96.78B | -21.41% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.06T |
| Genmab | 110.23B |
| ALK-Abelló | 47.68B |
| Demant | 42.77B |
| H. Lundbeck | 38.62B |
| Zealand Pharma | 20.37B |
| Ambu A/S | 17.38B |
| Bavarian Nordic | 15.27B |